Towa completes acquisition of Esteve's Generic Division

[ January 31, 2020 ]

Berlin, CT January 31, 2020 – Breckenridge Pharmaceutical, Inc. announced today that Towa Pharmaceutical Co., Ltd. has completed its acquisition of Esteve’s generics division, including Breckenridge.


Towa Pharmaceutical, based in Osaka, Japan, has been dedicated to the research and development, production, and marketing of generic drugs since 1951. With a team of more than 3,100 employees, its annual sales were 105,104 million yen for the year ended March 31, 2019. Towa’s shares are listed on the Tokyo Stock Exchange (TSE).